Education
About Us
Working with TipRanks
Follow Us
Ventyx Biosciences (VTYX)
NASDAQ:VTYX
RESEARCH TOOLSreports
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ -941.00K | $ -470.00K | $ -30.00K | $ 0.00 |
| Operating Income | $ -148.45M | $ -207.99M | $ -113.14M | $ -67.15M | $ -7.05M |
| EBITDA | $ -148.45M | $ -207.84M | $ -107.96M | $ -67.12M | $ 0.00 |
| Net Income | $ -135.12M | $ -192.96M | $ -107.96M | $ -78.37M | $ -28.53M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 217.32M | $ 252.22M | $ 356.61M | $ 286.72M | $ 244.00K |
| Total Assets | $ 276.56M | $ 277.69M | $ 371.40M | $ 291.48M | $ 245.00K |
| Total Debt | $ 10.79M | $ 12.51M | $ 1.56M | $ 0.00 | $ 12.65M |
| Net Debt | $ -16.47M | $ -39.07M | $ -63.26M | $ -70.79M | $ 12.40M |
| Total Liabilities | $ 22.52M | $ 33.77M | $ 17.50M | $ 12.28M | $ 30.90M |
| Stockholders' Equity | $ 254.04M | $ 243.92M | $ -226.22M | $ -117.80M | $ -30.65M |
| Cash Flow | |||||
| Free Cash Flow | $ -131.11M | $ -167.04M | $ -99.05M | $ -38.91M | $ -6.20M |
| Operating Cash Flow | $ -130.87M | $ -166.52M | $ -98.77M | $ -38.65M | $ -6.20M |
| Investing Cash Flow | $ -15.51M | $ 100.94M | $ -74.93M | $ -214.37M | $ 0.00 |
| Financing Cash Flow | $ 122.11M | $ 53.33M | $ 167.77M | $ 323.55M | $ 6.13M |